history of glp-1 drugs Discovery GLP-1–Based for the Treatment of Obesity Market Overview: GLP-1 Agonists and

Several ongoing clinical trials, including the ELAD trial investigating liraglutide in Alzheimers disease and the Exenatide-PD trial in Parkinsons disease, aim to further clarify the neuroprotective potential of GLP-1RAs (Femminella et al

Strategies for weight loss with GLP-1s: For those considering or currently using GLP-1 medications, here are several strategies that can enhance their effectiveness while minimizing side effects

10.1002/oby.21718 37 IacobellisG.Villasante FrickeA

Increases lipid oxidation, promoting fat breakdown rather than storage

Various methods were employed to measure gastric emptying in studies that included patients taking different GLP-1 medications, including both long-acting and short-acting formulations

doi: 10.1056/NEJMp2400978 [DOI] [PubMed] [Google Scholar] Associated Data This section collects any data citations, data availability statements, or supplementary materials included in this article.